Ripple kopen? Dit zijn de mogelijkheden

Gilead Sciences Aandeel

64,32USD 0,19USD 0,30%

Gilead Sciences Inc. - Profiel

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. Its primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.


Eigenaar in %
The Vanguard Group, Inc.7,83
Capital Research & Management Co. (Global Investors)6,15
BlackRock Fund Advisors5,12
SSgA Funds Management, Inc.4,61
Geode Capital Management LLC1,39
Dodge & Cox1,36
Northern Trust Investments, Inc.(Investment Management)1,35
Capital Research & Management Co. (World Investors)1,28
Invesco Capital Management LLC1,04
Norges Bank Investment Management1,00
Renaissance Technologies LLC1,00
T. Rowe Price Associates, Inc. (Investment Management)0,95
Fidelity Management & Research Co.0,93
Sanders Capital LLC0,91
AllianceBernstein LP0,87


333 Lakeside Drive, 94404 Foster City
Telefoon: 16505743000
Fax: 16505789264


Robin L. Washington MBA, CPA
CFO, Chief Accounting Officer & Executive VP
Daniel O'Day, MBA
Chairman & Chief Executive Officer
Johanna Mercier
Chief Commercial Officer
Gregg H. Alton
Chief Patient Officer
George Pratt Shultz, PhD
Andrew D. Dickinson
Executive VP-Corporate Development & Strategy
Jyoti Mehra
Executive Vice President-Human Resources
William A. Lee, PhD
Executive Vice President-Research
Jacqueline K. Barton, PhD
Independent Director
Per Wold-Olsen, MBA
Independent Director
Gayle Edlund Wilson
Independent Director
Harish M. Manwani
Independent Director
Kevin E. Lofton
Independent Director
Richard J. Whitley, MD
Independent Director
Kelly A. Kramer
Independent Director
John Francis Cogan, PhD
Lead Independent Director
Brett A. Pletcher
Secretary, Chief Compliance Officer & Executive VP
Diana Brainard, MD
Senior VP-HIV & Emerging Viral Infections
Michael Louie
Vice President-Information Systems
Sung Lee
Vice President-Investor Relations

Invoer toevoegen